What does ACT-A mean in UNITED NATIONS
ACT-A stands for Access to COVID-19 Tools Accelerator, a global initiative launched in April 2020 to accelerate the development, production, and equitable distribution of COVID-19 tests, treatments, and vaccines.
ACT-A meaning in United Nations in Governmental
ACT-A mostly used in an acronym United Nations in Category Governmental that means Access to COVID-19 Tools Accelerator
Shorthand: ACT-A,
Full Form: Access to COVID-19 Tools Accelerator
For more information of "Access to COVID-19 Tools Accelerator", see the section below.
ACT-A's Mission
ACT-A aims to:
- Develop and deploy safe and effective COVID-19 diagnostics, therapeutics, and vaccines
- Strengthen health systems to deliver these tools to those who need them most
- Provide equitable access to these tools for all, regardless of income or location
ACT-A's Pillars
ACT-A has four main pillars:
- Diagnostics: Developing, producing, and distributing rapid, reliable COVID-19 tests
- Therapeutics: Developing and scaling up production of effective treatments for COVID-19
- Vaccines: Developing, evaluating, and distributing a safe and effective COVID-19 vaccine
- Health Systems Strengthening: Supporting health systems in implementing COVID-19 tools and delivering essential health services
ACT-A's Partners
ACT-A is a collaboration between governments, global health organizations, manufacturers, and civil society groups, including:
- World Health Organization (WHO)
- United Nations Children's Fund (UNICEF)
- The Global Fund to Fight AIDS, Tuberculosis and Malaria
- The Bill & Melinda Gates Foundation
- Gavi, the Vaccine Alliance
ACT-A's Funding
ACT-A is funded through voluntary contributions from governments, international organizations, and philanthropic foundations. As of December 2022, ACT-A had received over $22 billion in pledges.
ACT-A's Impact
ACT-A has played a vital role in the global COVID-19 response. To date, ACT-A has:
- Distributed over 1 billion COVID-19 tests
- Supported the delivery of over 600 million doses of COVID-19 vaccines
- Provided funding for research and development of new COVID-19 diagnostics, therapeutics, and vaccines
Conclusion
ACT-A is a critical global partnership that has made significant progress in accelerating access to COVID-19 tools. By continuing to support ACT-A, we can ensure that everyone, everywhere has access to the life-saving tools they need to fight COVID-19.
Essential Questions and Answers on Access to COVID-19 Tools Accelerator in "GOVERNMENTAL»UN"
What is ACT-A?
Access to COVID-19 Tools Accelerator (ACT-A) is a global collaboration aimed at accelerating the development, production, and equitable distribution of COVID-19 tests, treatments, and vaccines.
What are the pillars of ACT-A?
ACT-A focuses on four key pillars: diagnostics, therapeutics, vaccines, and health system strengthening.
Who is involved in ACT-A?
ACT-A is a partnership between governments, health organizations (including WHO and UNICEF), scientists, manufacturers, and civil society groups.
How does ACT-A work?
ACT-A coordinates efforts to identify and develop promising COVID-19 tools, accelerate their production, and ensure their equitable allocation worldwide.
What are the goals of ACT-A?
ACT-A aims to provide 2 billion COVID-19 vaccine doses, 245 million treatment courses, and 500 million diagnostic tests by 2022.
How is ACT-A funded?
ACT-A is funded through voluntary contributions from governments, multilateral institutions, and private donors.
What is the role of COVAX within ACT-A?
COVAX is a key part of ACT-A, responsible for coordinating the procurement and distribution of COVID-19 vaccines to low- and middle-income countries.
How can I support ACT-A?
You can support ACT-A by donating funds, volunteering, or advocating for its work.